Michael J. Theodorakis

3.2k total citations · 1 hit paper
27 papers, 1.8k citations indexed

About

Michael J. Theodorakis is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael J. Theodorakis has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael J. Theodorakis's work include Diabetes Treatment and Management (14 papers), Diabetes Management and Research (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). Michael J. Theodorakis is often cited by papers focused on Diabetes Treatment and Management (14 papers), Diabetes Management and Research (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). Michael J. Theodorakis collaborates with scholars based in United States, Greece and United Kingdom. Michael J. Theodorakis's co-authors include Josephine M. Egan, Olga D. Carlson, Magdalena Juhaszova, Michel Bernier, Jie Zhou, Robert F. Margolskee, Sic L. Chan, X.Z. Shawn Xu, Hyeon Ho Kim and Byung-Joon Kim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Diabetes Care and Diabetes.

In The Last Decade

Michael J. Theodorakis

27 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1

2007 813 citations Hyeung-Jin Jang, Zaza Kokrashvili et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael J. Theodorakis United States	14	803	738	494	464	355	27	1.8k
Tongzhi Wu Australia	32	1.5k 1.8×	447 0.6×	780 1.6×	349 0.8×	122 0.3×	132	2.8k
Anne Christin Meyer‐Gerspach Switzerland	20	512 0.6×	359 0.5×	381 0.8×	280 0.6×	65 0.2×	50	1.6k
Dorte X. Gram Denmark	13	575 0.7×	155 0.2×	346 0.7×	221 0.5×	172 0.5×	15	1.4k
Lourdes Garrido‐Sánchez Spain	26	285 0.4×	258 0.3×	482 1.0×	177 0.4×	65 0.2×	79	1.8k
Fang Sun China	23	681 0.8×	228 0.3×	1.2k 2.5×	58 0.1×	183 0.5×	70	2.7k
Ilaria Palumbo Italy	21	337 0.4×	144 0.2×	240 0.5×	65 0.1×	36 0.1×	52	1.5k
Stuart M. Furler Australia	31	691 0.9×	266 0.4×	460 0.9×	224 0.5×	19 0.1×	49	3.0k
Deirdre O’Donovan Australia	16	381 0.5×	214 0.3×	276 0.6×	245 0.5×	17 0.0×	20	1.0k
Yinxing Ni China	13	281 0.3×	150 0.2×	150 0.3×	73 0.2×	260 0.7×	26	966
S Domschke Germany	29	258 0.3×	183 0.2×	903 1.8×	128 0.3×	88 0.2×	122	2.3k

Countries citing papers authored by Michael J. Theodorakis

Since Specialization

Citations

This map shows the geographic impact of Michael J. Theodorakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Theodorakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Theodorakis more than expected).

Fields of papers citing papers by Michael J. Theodorakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Theodorakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Theodorakis. The network helps show where Michael J. Theodorakis may publish in the future.

Co-authorship network of co-authors of Michael J. Theodorakis

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Theodorakis. A scholar is included among the top collaborators of Michael J. Theodorakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Theodorakis. Michael J. Theodorakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Katsiki, Niki, Dimitri P. Mikhailidis, & Michael J. Theodorakis. (2017). Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): Their Role in Cardiometabolic Risk Management. Current Pharmaceutical Design. 23(10). 1522–1532. 39 indexed citations

Theodorakis, Michael J., et al.. (2016). Modeling the oral glucose tolerance test in normal and impaired glucose tolerant states: a population approach. Current Medical Research and Opinion. 33(2). 305–313. 3 indexed citations

Françès, C., Victoria Stokes, Garry D. Tan, & Michael J. Theodorakis. (2015). Insulin dose adjustments with add-on glucagon-like peptide-1 receptor (GLP-1R) agonists in clinical practice. Expert Opinion on Pharmacotherapy. 16(10). 1417–1421. 11 indexed citations

Holman, Rury R., M. Angelyn Bethel, Juliana C.N. Chan, et al.. (2014). Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial. American Heart Journal. 168(1). 23–29.e2. 42 indexed citations

Standl, Eberhard, Michael J. Theodorakis, Michael Erbach, Oliver Schnell, & Jaakko Tuomilehto. (2014). On the potential of acarbose to reduce cardiovascular disease. Cardiovascular Diabetology. 13(1). 81–81. 44 indexed citations

Mathieu, Chantal, S. Matthäei, Matthew Reaney, et al.. (2013). Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE. Diabetes Therapy. 4(2). 285–308. 12 indexed citations

Reaney, Matthew, Chantal Mathieu, Claes‐Göran Östenson, et al.. (2013). Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study. Health and Quality of Life Outcomes. 11(1). 217–217. 21 indexed citations

Theodorakis, Michael J., Matthew Reaney, David F. Bruhn, et al.. (2011). PDB49 Resource Use in Patients with Type 2 Diabetes (T2D) Who Initiated Exenatide BID (EXBID) or Starter Insulin (INS) Therapy: 6-Month Data from Choice. Value in Health. 14(7). A480–A480. 1 indexed citations

Liakou, Aikaterini Ι., Michael J. Theodorakis, & Christos C. Zouboulis. (2011). Nutritional Clinical Studies in Dermatology. PubMed. 12(10). 209–220. 11 indexed citations

10.

Tsagalis, George, et al.. (2009). Long-Term Prognosis of Acute Kidney Injury after First Acute Stroke. Clinical Journal of the American Society of Nephrology. 4(3). 616–622. 74 indexed citations

11.

Zakopoulos, Nikolaos, Konstantinos Dolianitis, Michael J. Theodorakis, et al.. (2008). Diurnal correlation of ambulatory blood pressure and interstitial glucose in patients with normal glucose tolerance. Blood Pressure Monitoring. 13(6). 309–317. 2 indexed citations

12.

Voidonikola, Paraskevi, Kimon Stamatelopoulos, Maria Alevizaki, et al.. (2008). The Association Between Glycemia and Endothelial Function in Nondiabetic Individuals: The Importance of Body Weight. Obesity. 16(12). 2658–2662. 8 indexed citations

13.

Jang, Hyeung-Jin, Zaza Kokrashvili, Michael J. Theodorakis, et al.. (2007). Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proceedings of the National Academy of Sciences. 104(38). 15069–15074. 813 indexed citations breakdown →

14.

Doyle, Maı̀re E., Patrick McConville, Michael J. Theodorakis, et al.. (2005). In Vivo Biological Activity of Exendin (1–30). Endocrine. 27(1). 1–10. 17 indexed citations

15.

Theodorakis, Michael J., Olga D. Carlson, Spyridon Michopoulos, et al.. (2005). Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. American Journal of Physiology-Endocrinology and Metabolism. 290(3). E550–E559. 304 indexed citations

16.

Doyle, Maı̀re E., Michael J. Theodorakis, Harold W. Holloway, et al.. (2003). The importance of the nine-amino acid C-terminal sequence of exendin-4 for binding to the GLP-1 receptor and for biological activity. Regulatory Peptides. 114(2-3). 153–158. 43 indexed citations

17.

Tanus‐Santos, José E. & Michael J. Theodorakis. (2002). Is There a Place for Inhaled Nitric Oxide in the Therapy of Acute Pulmonary Embolism?. PubMed. 1(3). 167–176. 18 indexed citations

18.

Cziráki, Attila, Iván Horváth, Joseph W. Rubin, Michael J. Theodorakis, & John D. Catravas. (2000). Quantification of pulmonary capillary endothelium-bound angiotensin converting enzyme inhibition in man. General Pharmacology The Vascular System. 35(4). 213–218. 2 indexed citations

19.

Ehrhart, I. C., Lihua Zou, Michael J. Theodorakis, et al.. (2000). Effect of nitrite on endothelial function in isolated lung. General Pharmacology The Vascular System. 34(6). 401–408. 4 indexed citations

20.

Dimopoulos, Meletios Α., et al.. (1997). Treatment of Langerhans Cell Histiocytosis with 2 Chlorodeoxyadenosine. Leukemia & lymphoma. 25(1-2). 187–189. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact